Large Molecule
Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis
Waters Corporation
PR-10-24-NI-38Oct 11, 2024
The PHASE Platform
How Synergistic Collaborations Between Outsourcing Partners Can Accelerate Clinical Success
Wheeler Bio
PAO-05-24-CL-01May 08, 2024
Outsourced Manufacturing
A Closer Look at Small Molecule Drug Substance and Drug Product Manufacturing
April Stanley, MS MBA
Nice Insight
PAO-03-24-NI-02Mar 27, 2024
Analytical Method Development
Harnessing Biologic Development Experience in Support of CDMO Clients: Rapid, Effective and Tailored Analytical Method Development
Xuemei Han, Ph.D.
Tanvex CDMO
PAO-03-24-CL-09Mar 13, 2024
Bispecific Antibodies
Accelerating the Development and Production of High-Quality Bispecific Antibodies
Dongyoung Park
Samsung Biologics
PAO-03-24-CL-01Mar 04, 2024
Biologics Formulation
Successful Formulation Development for Biologics Using a Unique Biophysical Prediction and Screening Platform
Pawel Stanczak, Ph.D.
Tanvex CDMO
PAO-02-24-CL-02Feb 15, 2024
Recombinant Antibody
Recombinant Antibody Technology is Crucial to Past and Future Success in Biopharma
Suranjana Sen, Ph.D.
Sino Biological
PAO-01-24-CL-4Jan 24, 2024
Glycosylation
S-Glyn™ : Optimizing N-Glycan Profiles and their Effector Functions Using a Design-of-Experiments Approach
Junyong Park
Samsung Biologics
PAO-12-23-CL-06Dec 14, 2023
Strategic Partnership
Samsung Biologics and Kurma Partners Announce Strategic Partnership for Development and Manufacturing of Biologics for Kurma’s Portfolio Companies
Samsung Biologics
PR-M10-23-06Oct 24, 2023
Insect Cell Expression
Innovations in Baculovirus–Insect Cell Expression Systems
Amy Sheng, Ph.D.; Yingmin Zhu, Ph.D.; Xuejiao Zhang, Ph.D.
Sino Biological
PAO-09-23-CL-01Aug 31, 2023
Quality Culture
Does Your Biologics CDMO Truly Have a Culture of Quality?
Joe Payne
Scorpius BioManufacturing
PAO-07-23-CL-07Jul 27, 2023
R&D
Integrating Digital Solutions to Streamline Biopharma Operations
Christian Olsen
Dotmatics
PAO-07-23-CL-06Jul 17, 2023
Leadership
Wheeler Bio Appoints Dr. Stewart McNaull as Chief Business Officer
Wheeler Bio
PR-M06-23-02Jun 06, 2023
Distribution
Redefining Innovation and Growth in Pharmaceutical Distribution
Ernest de Freitas
Univar Solutions
PAO-06-23-CL-03Jun 06, 2023
Biomanufacturing
Biologics Outsourcing: Decision Drivers and Key Considerations
Scorpius BioManufacturing
PAO-04-23-CL-01Apr 18, 2023
Tumor Microenvironment
Harnessing the Power of the Tumor Microenvironment with First-in-Class Therapies
Gil Efron
Purple Biotech
PAO-03-23-CL-01Mar 21, 2023
Scale-Up
Scale-Up Expertise to Support Your Biologics Life Cycle
Pramthesh (Prem) Patel, Ph.D.
Avid Bioservices
PAO-02-23-CL-06Mar 02, 2023
Antibody Production
From Llamas to Yeast: Producing Functional Therapeutic Antibody Fragments in Saccharomyces cerevisiae
Phenotypeca
PAO-01-23-CL-05-153Feb 01, 2023
Biomanufacturing
An Experienced CDMO Can Be a Differentiator in the Rapidly Growing Biologics Market
Scorpius BioManufacturing
PAO-01-23-CL-04Jan 31, 2023
Anti-Idiotype Antibodies
Rapid Supply of Anti-Idiotype Antibodies Facilitates Preclinical and Clinical Antibody-Based Drug Development
Na Li, Ph.D.
Sino Biological
PAO-01-23-CL-01Jan 13, 2023